Analyst Ratings for NxStage Medical (NXTM)

NXTM Rating Summary

NXTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NXTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $17.50 (+0.5%) * Over Last 12-Mos
Rating Score: 5.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/11/2014 Wells Fargo Downgrade Underperform
(Market Perform)
11.00
(12.50)
14.66 17.42 18.83% Details
7/26/2013 Lazard Capital Downgrade Neutral
(Buy)
N/A
(N/A)
13.59 17.42 28.18% Details
Like NXTM Ratings? Also take a look at FMS, RWLK

NXTM Ratings News